Apolipoprotein C-II Deficiency (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
3
|
5
|
0.750 |
None |
1.000 |
9 |
5
|
1993 |
2017 |
Hyperlipoproteinemia Type I
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
36
|
64
|
0.400 |
None |
1.000 |
11 |
|
1981 |
2018 |
Familial apolipoprotein C-II deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
3
|
|
0.330 |
None |
1.000 |
4 |
|
1979 |
2018 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Drug Eruptions
|
group |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
41
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Morbilliform Drug Reaction
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Amyloidosis
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
694
|
93
|
0.300 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Hypertriglyceridemia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
340
|
169
|
0.200 |
None |
0.960 |
25 |
1
|
1992 |
2019 |
Pancreatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
502
|
80
|
0.160 |
None |
1.000 |
6 |
|
1998 |
2020 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.140 |
None |
0.800 |
5 |
1
|
1987 |
2018 |
Myotonic Dystrophy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
155
|
4
|
0.100 |
None |
1.000 |
23 |
|
1985 |
2007 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Lipidemia retinalis
|
disease |
Eye Diseases
|
Disease or Syndrome
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
APOLIPOPROTEIN C-II VARIANT PHENOTYPE
|
phenotype |
|
Finding
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Splenomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
345
|
19
|
0.100 |
None |
|
0 |
|
|
|
Eruptive xanthoma
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
4
|
1
|
0.100 |
None |
|
0 |
|
|
|
APOLIPOPROTEIN C-II (SAN FRANCISCO)
|
phenotype |
|
Finding
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
APOLIPOPROTEIN C-II (BARI) PHENOTYPE
|
phenotype |
|
Finding
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
APOLIPOPROTEIN C-II (PADOVA) PHENOTYPE
|
phenotype |
|
Finding
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
APOLIPOPROTEIN C-II (PARIS) PHENOTYPE
|
phenotype |
|
Finding
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Hepatomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Finding
|
523
|
30
|
0.100 |
None |
|
0 |
|
|
|
apolipoprotein C-II (Wakayama) phenotype
|
phenotype |
|
Finding
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|